Singapore got Pfizer vaccine quicker because Temasek Holdings had a stake in BioNTech, says KJ


KUALA LUMPUR: Among the reasons why Singapore was ahead of Malaysia in procuring Covid-19 vaccines was because Temasek Holdings and other investors had invested US$250mil (RM1.06bil) into German biotech company BioNTech, says Khairy Jamaluddin.

The Science, Technology and Innovation Minister said it was likely that Singapore was prioritised by BioNTech, which developed the Pfizer-BioNTech Covid-19 vaccine in a joint venture with Pfizer, because Temasek Holdings has a stake in the company.

Subscribe or renew your subscriptions to win prizes worth up to RM68,000!

Monthly Plan

RM13.90/month

Annual Plan

RM12.33/month

Billed as RM148.00/year

1 month

Free Trial

For new subscribers only


Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
   

Next In Nation

Don't take Malaysia's racial unity, diversity for granted, says Unity Minister
India reports 'good progress' in Asean-India trade pact review talks
Thunderstorms expected in 11 states, two FTs till 9pm tonight, says MetMalaysia
Logistics and connectivity: Cornerstones of Asean development, says Dr Wee
Sultan Nazrin attends state-level Deepavali celebrations
No evidence Pantai Esen pollution due to Silicon Island reclamation works, says exco rep
Johor cops looking for man in alleged child molestation case
MCMC to explore non-SMS disaster alert channel, says Fahmi
M. Nasir says honorary doctorate is career's highest honour
Google, Microsoft praise M'sia's approach to building AI infrastructure, roadmap

Others Also Read